Odunsi K, Terry G, Ho L, Bell J, Cuzick J, Ganesan T S
ICRF Molecular Oncology Laboratories, John Radcliffe Hospital, Oxford, United Kingdom.
Mol Med. 1995 Jan;1(2):161-71.
Cervical intraepithelial neoplasia (CIN) and cervical cancer have been shown to be strongly associated with infection by human papillomavirus (HPV). However, other factors may be contributory in the progression from normal epithelium to CIN and cervical cancer, since not all women with HPV infection develop disease. Recently, it was demonstrated that there is a high risk for cervical cancer and CIN in women with HLA DQB1 * 03 (RR = 7.1, p < 0.0009) (1). Subsequent reports have been conflicting, due to sample size, genetic heterogeneity and differences in the techniques employed for the detection of HLA DQB1 * 03.
DNA from cervical smears of 178 women with CIN and 420 controls with normal cervical cytology was analyzed by polymerase chain reaction (PCR) with type-specific primers for HPV 16, 18, 31, and 33. The DNA from test and control samples were also analyzed by a novel PCR technique, which mutates the first base of codon 40 (DQ alleles) from T to G to create an artificial restriction site for an enzyme Mlu I that distinguish DQB1 * 03 from other alleles and are confirmed by digestion of amplified DNA with Mlu I. Further analysis of individual DQB1 * 03 alleles was performed using PCR and allele-specific primers.
One hundred forty-four (34%) out of 420 controls (all HPV 16, 18, 31, or 33 negative and normal cytology), 37/66 (56%) of CIN I and 72/112 (64%) of CIN III were positive for DQB1 * 03 (trend test, p < 0.001, chi 2 = 37.3). A significant association was observed between DQB1 * 03 and CIN (odds ratio 3.03; 95% CI 2.11-3.45). Of women with CIN, 131/178 (73.5%) had HPV (types 16, 18, 31, or 33) infection. There was a significant association between DQB1 * 03 and presence of HPV (odds ratio 3.43; 95% CI 2.25-5.10). Homozygosity for DQB1 * 03 was more strongly associated with CIN than heterozygosity (odds ratios 4.0 and 2.63, respectively); and for the presence of HPV (odds ratio 4.47; 95% CI 2.58-7.77). HLA DQB1 * 0301 was the most strongly associated allele with CIN and HPV (odds ratios 2.53 and 2.63, respectively).
HLA DQB1 * 03 is associated significantly with CIN and may be permissive for HPV infection. Further analysis of class II HLA typing in CIN is necessary to evaluate this association.
宫颈上皮内瘤变(CIN)和宫颈癌已被证明与人乳头瘤病毒(HPV)感染密切相关。然而,其他因素可能在从正常上皮发展为CIN和宫颈癌的过程中起作用,因为并非所有感染HPV的女性都会发病。最近,研究表明携带HLA DQB1 * 03的女性患宫颈癌和CIN的风险较高(相对危险度=7.1,p<0.0009)(1)。由于样本量、基因异质性以及检测HLA DQB1 * 03所采用技术的差异,后续报告的结果相互矛盾。
采用针对HPV 16、18、31和33的型特异性引物,通过聚合酶链反应(PCR)分析178例CIN女性宫颈涂片和420例宫颈细胞学正常对照者的DNA。还采用一种新型PCR技术分析检测样本和对照样本的DNA,该技术将密码子40(DQ等位基因)的第一个碱基从T突变为G,从而为Mlu I酶创造一个人工限制性位点,以此区分DQB1 * 03与其他等位基因,并通过用Mlu I消化扩增的DNA进行确认。使用PCR和等位基因特异性引物对单个DQB1 * 03等位基因进行进一步分析。
420例对照者(均为HPV 16、18、31或33阴性且细胞学正常)中有144例(34%)、CIN I患者中的37/66例(56%)以及CIN III患者中的72/112例(64%)DQB1 * 03呈阳性(趋势检验,p<0.001,χ2=37.3)。观察到DQB1 * 03与CIN之间存在显著关联(比值比3.03;95%可信区间2.11 - 3.45)。CIN女性中,131/178例(73.5%)感染了HPV(16、18、31或33型)。DQB1 * 03与HPV感染之间存在显著关联(比值比3.43;95%可信区间2.25 - 5.10)。DQB1 * 03纯合子与CIN的关联比杂合子更强(比值比分别为4.0和2.63);与HPV感染的关联也是如此(比值比4.47;95%可信区间2.58 - 7.77)。HLA DQB1 * 0301是与CIN和HPV关联最强劲的等位基因(比值比分别为2.53和2.63)。
HLA DQB1 * 03与CIN显著相关,可能对HPV感染具有易感性。有必要对CIN中的II类HLA分型进行进一步分析以评估这种关联。